Home › Marginal Zone Lymphoma

Marginal Zone Lymphoma clinical trials recruiting in the U.S.

55 studies for Marginal Zone Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

• Durham, NC12 studies
• New York City, NY11 studies
• Milwaukee, WI9 studies
• Seattle, WA9 studies
• Boston, MA9 studies
• Baldwin Park, CA9 studies
• Columbus, OH8 studies
• Edison, NJ8 studies
• Houston, TX8 studies
• Rochester, MN8 studies
• Denver, CO7 studies
• Miami, FL7 studies
• Salt Lake City, UT6 studies
• Jacksonville, FL6 studies
• Nashville, TN6 studies
• St. Louis, MO6 studies
• Dallas, TX5 studies
• Portland, OR5 studies
• Queens, NY5 studies
• Greenburgh, NY5 studies
• Chicago, IL5 studies
• Washington, DC5 studies
• Cleveland, OH5 studies
• Atlanta, GA5 studies
• Cincinnati, OH4 studies
• Buffalo, NY4 studies
• Staten Island, NY4 studies
• New Rochelle, NY4 studies
• Los Angeles, CA4 studies
• Tampa, FL4 studies
• Minneapolis, MN4 studies
• Philadelphia, PA4 studies
• Providence, RI3 studies
• Mountain View, CA3 studies
• East Norwalk, CT3 studies
• Richmond, VA3 studies
• Scottsdale, AZ3 studies
• Cedar Rapids, IA3 studies
• New Haven, CT3 studies
• Ann Arbor, MI3 studies

By state

• Arizona5 studies
• California18 studies
• Colorado8 studies
• Connecticut4 studies
• Florida15 studies
• Georgia6 studies
• Illinois6 studies
• Iowa4 studies
• Kansas3 studies
• Maryland6 studies
• Massachusetts12 studies
• Michigan5 studies
• Minnesota12 studies
• Missouri6 studies
• New Jersey9 studies
• New York16 studies
• North Carolina14 studies
• Ohio13 studies
• Oregon5 studies
• Pennsylvania5 studies
• Rhode Island3 studies
• Tennessee7 studies
• Texas12 studies
• Utah6 studies
• Virginia4 studies
• Washington10 studies
• Wisconsin10 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.